Renasant (RNST) reports Q2 earnings: What key metrics have to say
|Renasant reported $267.19 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 63.1%. EPS of $0.69 for the same period compares to $0.69 a year ago.
The reported revenue represents a surprise of +3.07% over the Zacks Consensus Estimate of $259.23 million. With the consensus EPS estimate being $0.74, the EPS surprise was -6.76%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Renasant performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
-
Net interest margin: 3.9% versus 3.7% estimated by three analysts on average.
-
Efficiency ratio (GAAP): 67.6% versus 62.2% estimated by three analysts on average.
-
Total nonperforming loans: $141.86 million versus the two-analyst average estimate of $102.76 million.
-
Annualized net loan charge-offs /average loans: 0.3% versus 0.1% estimated by two analysts on average.
-
Total nonperforming assets: $153.61 million versus the two-analyst average estimate of $114.25 million.
-
Average balance - Total interest-earning assets: $23.21 billion versus the two-analyst average estimate of $23.16 billion.
-
Net Interest income: $218.86 million versus the three-analyst average estimate of $209.28 million.
-
Net interest income (FTE): $222.72 million versus $213.71 million estimated by three analysts on average.
-
Total noninterest income: $48.33 million versus the three-analyst average estimate of $49.97 million.
Want the latest recommendations from Zacks Investment Research? Download 7 Best Stocks for the Next 30 Days. Click to get this free report
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.